ϸ°ûÉúÎïѧ£º ` 4s#5g
Ò»¡¢ Ãû´Ê½âÊÍ£º lW{I`r\]
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£© RW|UQY#
2£® PCR£¨96£© {,nd_3"Vq
3£® ·ºËØ£¨ubquitin£©£¨96£© -o!saX<
4£® °é·Ö×Ó£¨chapron£©£¨96£© B1 jH.(
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£© `Z;B^Y0
6£® DG£IP3£¨96£© S4@117z5
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© vZ1D3ytfG
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© !VJT"Ds_
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© )[^:]}%r
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© _BeX7
11£® Transformation£¨92£© (AyRs7Dkn
12£® TransfectionתȾ£¨92£© 3!ajvSOI9j
13£® Transcytosis×ªÒÆ×÷Óã¨92£© 3V8j>&
14£® Transductionתµ¼£¨92£© h:US]ZC^Z
15£® Transdetermination£¨92£© z~A(IQO
16£® Transdifferentiation£¨92£© s525`Q;
17£® Transgenic animalת»ùÒò¶¯Î92£© NZi'eZ{^`
18£® Rb£1£¨92£© R, (+NT$
19£® P53£¨92¡¢91£© FHnHhB [
20£® C£jun£¨92£© \sXmMc
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© O7L6Htya
22£® °ûÄÚÌ壨99£© :` !mCW`Q-
23£® Cyclin dependent kinase inhibitor(CDKI)(99) G1n>@Y'j''
24£® G£protein£¨91£© Q%b46"
25£® Restriction point£¨91£© PHB\)/
26£® Antipost£¨91£© N]<~NG:6b
27£® Capping£¨91£© ~jrU#<'G9
28£® TATAbox£¨91£© !UPAEA
29£® cDNA library£¨90£© v2dSC(hRZ
30£® Aritotic apparatus£¨90£© L52z
31£® ¿çĤÐźŠtransmembrane signal£¨90£© s#8{:ko
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£© D-;43>yi<
33£® Nuclear lamina£¨90£© )="g?E3
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£© }e;p8)]Wl
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© @o-evH;G
36£® ϸ°û·Ö»¯£¨00£© rt4|GVa
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£© 3ks|
38£® ¿Ë¡£¨00£© l>Oe ,`9O
39£® »ùÒò×飨00£© e[Ul"pMvS`
40£® Caspase£¨00£© UW~tS
41£® ת¼Òò×Ó£¨00£© U1@P/
42£® ÅßÌ¥¸Éϸ°û£¨01£© s?gXp{O?X
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© ieK'<%dxF
44£® DNAоƬ£¨01£© I5AjEp
¶þ¡¢ ÎÊ´ðÌ⣺ CX@HG)l
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© "\P~Re"EH
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æä¹¦ÄÜ£¨95£© vskM
;
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© dXr
!_)i
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© Nl>b'G96
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£© |x~ei_x7.p
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£© UmHb-uk ;
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© kO O~%|1CP
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£© xo@/k
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© zj0pP{y
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿ØÏ¸°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£© w2_I/s6B
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷ÍÆ¶¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£© gl4
f9Ff
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© BB}iBf I'
13£® ϸ°û¹Ç¼ÜÔÚϸ°ûÔöÖ³ÖÜÆÚÖеÄ×÷Óã¨00£© !h
aXO
14£® P34cdc2µÄÐÔÖʼ°Æä×÷Óõ×ÎïÊÇʲô£¿½«ÒýÆðºÎÖÖЧӦ£¿£¨91£© "g&l~N1$
15£® ϸ°ûÓÐË¿·ÖÁÑÖзĴ¸Ìå΢¹ÜµÄ¶¯Á¦Ñ§±ä»¯»úÀí¼°ÆäÓëȾɫÌåÔ˶¯µÄ¹ØÏµ£¨95£© m_W.r+s~C4
16£® ΢¹ÜµÄ×é×°ÓëÈ¥×é×°ÔÚϸ°ûÓÐË¿·ÖÁѹý³ÌÖеĶ¯Ì¬±ä»¯¼°Æä×÷Óã¨92£© vVR
CM
17£® ϸ°ûÓÐË¿·ÖÁѹý³ÌÖзĴ¸ÌåµÄ×é×°ÓëÈ¥×é×°µÄ¶¯Ì¬±ä»¯¼°Æä¹¦ÄÜ£¨93£© k{$"-3
ed
18£® ϸ°ûÓÐË¿·ÖÁѺóÆÚȾɫÌå·ÖÀëÇ÷ÏòÁ½¼«µÄ»úÀíÊÇÈçºÎÖ¤Ã÷µÄ£¿£¨90£© q+=@kXs>+
19£® ÊÔÊöÖÐÐÄÁ£/¶¯Á£È¥ÔÚϸ°ûÓÐË¿·ÖÁÑÖеÄ×÷Óã¨99£© 9(\N+
20£® KinetochoreÊÇÓÉÄļ¸ÖÖÖ÷Òªµ°°××é³É£¬ÓÃʲô·½·¨Ñо¿Æä¶¨Î»¡¢·Ö×ÓÁ¿¼°»úÄÜ£¿£¨90£© d3hTz@JY
21£® ÊÔ·Ö±ðÐðÊöÈËÀà×ÅË¿Á£ºÍ¶¯Á£µÄ»ù±¾×é³É¼«ÆäĿǰËùÖªµÄ¹¦ÄÜ£¨01£©
WN?`Od:y
22£® ÊÔÊöϸ°û±à³ÌÐÔËÀÍö£¨programmed cell death£©ºÍϸ°ûµòÍö£¨apoptosis£©µÄÌØÕ÷ºÍÉúÀíѧÒâÒå¼°Æä¿ÉÄܵĻùÒòµ÷¿Ø£¬ÄãÈÏΪÑо¿µÄÖØµãÓ¦·ÅÔں䦣¿ÎªÊ²Ã´£¿£¨95£© '
=s*DL`0
23£® ApoptosisÓëneerosisµÄ¼ì²âÓëÇø±ð£¨99£© ~.=HN}E
24£® ÈçºÎ¼ø±ðϸ°ûµòÍöÓ뻵ËÀ¡£Ï¸°ûµòÍöÑо¿µÄÖØÒªÒâÒåÊÇʲô£¿£¨01£© |0Ug~jKU
25£® ÊÔÊöunipintin£proteasen proteolytic system£¨99£© "U~@o4u;
26£® ÒÑÖªÓÐÄÇЩÖ÷ÒªµÄ°©»ùÒòÓëÒÖ°©»ùÒòÓëϸ°ûÖÜÆÚµÄµ÷¿ØÓйأ¿²¢¾ÙÀý˵Ã÷£¨93£© c35vjYQx0
27£® Oncogene¼°Æä²úÎïÓëϸ°ûÔöÖ³µÄ¹ØÏµ£¨91£© |L#r)$n{1
28£® ¾ÙÀý˵Ã÷oncogene¡¢growth factors¼°ÊÜÌåÖ®¼äµÄÁªÏµ£¨90£© tWy<9TF
29£® ÊÔÊöºáÎÆ¼¡¡¢Ï¸°ûÄÚ´Öϸ˿Á½·Ö×ӵĽṹ¡¢¸÷ÖÖÖ÷Òªµ°°×³É·ÖÔÚ¼¡ÈâÊÕËõÖеÄ×÷Óᣣ¨90£© JH,fg K+[
30£® ÊÔÊöϸ°ûÖÊÃþÉÏĤµ°°×µÄ¼¸ÖÖÀàÐͼ°Æä¹¦ÄÜ£¨95£© z:?
<aT
31£® ÊÔÊöÃâÒßѧ¼¼ÊõÔÚϸ°ûÉúÎïѧÑо¿ÖеÄÓ¦Óã¨92£© nqW:P$
32£® ͬԴºÐµÄ·¢ÏÖ¼°ÆäÔÚÉúÎïÖеÄÖØÒªÒâÒ壨92£© Ol^EQLO
33£® ÈçÒÑ֪ijһ»ùÒòƬ¶ÎÐòÁкÍÒÑ»ñµÃijһµ¥¿Ë¡¿¹ÌåÓ¦ÓúÎÖÖ¼¼Êõ·Ïߵõ½ËüµÄcDNA¿Ë¡£¨94£© QE6-(/
34£® ¾ÙÀý˵Ã÷ÃâÒßÓ«¹âFISH¡¢ÃâÒߵ羵ÖîÏî¼¼ÊõµÄ»ù±¾ÔÀí¼°ÆäÔÚϸ°ûÉúÎïѧÑо¿Öеĸ÷½â¾öʲôÎÊÌ⣨94£© mhSsOmJ5
35£® ÄãµÄ˶ʿÂÛÎÄÌá³öÁËʲôÎÊÌ⣿ÈçºÎ½â¾öµÄ£¿½áÂÛÊÇʲô£¿£¨96¡¢94¡¢00£©